These findings supported the hypothesis of a feedback amplification circuitry in which ChREBP-mediated p85α expression exacerbates PI3K/AKT signaling to drive HK2 expression, which then potentiates ChREBP activity to promote HCC development (Fig. 5h). The gene discussed is AKT1; the disease is hepatocellular carcinoma.